Delisted Securities
Equity instruments that have been removed from a regulated exchange but continue to exist as legal ownership interests.
We provide institutional access and structured evaluation support for securities that are no longer actively traded, have limited market liquidity, or have become difficult to transfer through conventional exchange mechanisms.

Illiquid securities represent financial instruments that have lost active market liquidity or are no longer efficiently tradable through standard exchange channels. This may occur due to delisting events, trading suspensions, corporate restructurings, regulatory changes, or prolonged inactivity in secondary markets.
While such securities are often perceived as inactive or non-performing from a market perspective, they remain legally valid ownership interests in the underlying issuing entity. In many cases, they may still represent exposure to corporate assets, restructuring outcomes, litigation recoveries, or future strategic transactions.
Our role is to evaluate these positions within a structured institutional framework and identify whether any potential recovery pathways, secondary market interest, or strategic transaction opportunities may exist.
Illiquid securities are financial instruments that cannot be easily sold or transferred without significant delay, discounting, or reliance on specialized transaction channels. These situations typically arise when:
In such circumstances, traditional price discovery mechanisms may no longer function effectively, leading to uncertainty around valuation and liquidity.
However, illiquidity does not automatically imply a lack of underlying value. It indicates that conventional trading infrastructure is no longer functioning for that specific instrument.
We evaluate a broad range of illiquid financial instruments across multiple jurisdictions and market environments.
Equity instruments that have been removed from a regulated exchange but continue to exist as legal ownership interests.
Securities subject to temporary or extended trading suspension due to regulatory, financial or corporate events.
Instruments traded on OTC markets with limited liquidity, pricing transparency or institutional participation.
Holdings subject to contractual, regulatory or transfer limitations that reduce marketability.
Long-term holdings in companies that no longer maintain active market presence or investor coverage.
Foreign-issued instruments with limited accessibility or fragmented secondary market infrastructure.
Illiquidity in securities markets typically results from structural, regulatory or corporate developments rather than a single isolated cause. Common drivers include:
Delistings, mergers, acquisitions, restructurings or bankruptcies.
Loss of exchange listing, reduced analyst coverage or withdrawal of market makers.
Compliance issues, reporting failures or jurisdictional restrictions.
Declining institutional participation or retail investor disengagement.
Transfer restrictions, custody issues or settlement inefficiencies.
Each factor affects market accessibility but does not necessarily eliminate underlying asset value.
Our approach to illiquid securities is based on structured analysis, documentation review and identification of potential transaction pathways.
Review of available security information, issuer details and market status.
Analysis of custody records, shareholder statements and relevant corporate documentation.
Evaluation of issuer condition, including restructuring activity, insolvency proceedings or strategic developments.
Assessment of whether secondary market interest or institutional demand may exist.
Identification of potential investors, special situations funds or strategic acquirers.
Evaluation of possible transfer structures and execution pathways.
Depending on the nature of the asset, illiquid securities may be addressed through several potential structures.
Direct sale between existing holder and qualified counterparty.
Aggregation of multiple holdings into a larger transferable position.
Involvement in corporate restructuring or recapitalization processes.
In certain insolvency contexts, securities may be converted into claims or recovery instruments.
Purchase of securities as part of broader corporate or asset-level transactions.
Each pathway is subject to legal, regulatory and counterparty considerations.
Illiquid securities are primarily of interest to specialized market participants who focus on complex, distressed or non-standard asset classes. Typical counterparties include:
These investors typically evaluate illiquid securities based on underlying asset value, restructuring potential or strategic positioning rather than short-term market pricing.
Transacting illiquid securities involves specific considerations that differ significantly from traditional equity markets. These may include:
Accordingly, each situation requires independent evaluation and cannot be generalized based on market benchmarks alone.
In some cases, illiquid securities may retain value depending on issuer circumstances, underlying assets, restructuring outcomes or potential strategic transactions. However, no outcome is guaranteed and each case must be assessed individually.
Yes, but typically only through specialized secondary market channels or direct transactions with qualified counterparties. Liquidity is not guaranteed and may require extended execution timeframes.
No. Any potential transaction depends on counterparty interest, due diligence outcomes and prevailing market conditions.
Typically institutional investors, special situations funds, hedge funds, private equity firms and strategic acquirers.
No content on this page constitutes financial, legal or investment advice. All activities are subject to applicable regulatory requirements.
If you hold securities that are no longer actively traded, have been delisted, or are otherwise difficult to transfer through conventional markets, our team can conduct a confidential preliminary assessment.
Submission does not guarantee valuation, liquidity or transaction execution. Each case is reviewed independently based on available information and market conditions.